Compare

Johnson & Johnson vs Eli Lilly

Johnson & Johnson (JNJ) and Eli Lilly (LLY) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

Johnson & Johnson JNJNYSE · PharmaceuticalsEli Lilly LLYNYSE · Pharmaceuticals
Insider records, last 12 months280378
Congress trades, last 12 months2524
Fund positions reported, last 12 months587709
Federal contract awards, last 12 months162
Open-market purchases by insiders since 20062535
Open-market sales by insiders since 20064406,838
Last open-market purchase by an insiderDec 1, 2025Aug 15, 2025
Next resultsOct 13, 2026Oct 29, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, Johnson & Johnson or Eli Lilly?

Since 2006, Eli Lilly insiders reported 35 open-market purchases against 25 for Johnson & Johnson, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade JNJ or LLY?

In the last 12 months, members of Congress disclosed 25 trades in Johnson & Johnson (JNJ) and 24 in Eli Lilly (LLY), each reported as a value range on a periodic transaction report.

When did insiders last buy JNJ and LLY?

Johnson & Johnson: Dec 1, 2025. Eli Lilly: Aug 15, 2025. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Johnson & Johnson free$9.99 a month, cancel anytime

Johnson & Johnson pageEli Lilly pageRare insider trades this weekAll comparisons

https://oqro.io/compare/jnj-vs-lly